Table 3.

Cost-effectiveness when intervention effect in most deprived quintile is 20 or 30% smaller than in the least deprived quintile.

	Least deprived, intervention fully effective		Most deprived, intervention 20% less effective		Most deprived, intervention 30% less effective
	Male	Female	Male	Female	Male	Female
Intervention effects (mean, 95% range)
Diabetes mellitus	0.966 (0.948 to 0.983)	0.967 (0.949 to 0.983)	0.973 (0.960 to 0.987)	0.974 (0.960 to 0.987)	0.977 (0.965 to 0.988)	0.977 (0.966 to 0.988)
Coronary heart disease	0.949 (0.924 to 0.973)	0.950 (0.927 to 0.975)	0.960 (0.940 to 0.981)	0.961 (0.942 to 0.979)	0.966 (0.948 to 0.983)	0.966 (0.949 to 0.982)
Stroke	0.968 (0.953 to 0.984)	0.967 (0.953 to 0.985)	0.975 (0.964 to 0.987)	0.976 (0.964 to 0.988)	0.979 (0.968 to 0.989)	0.979 (0.968 to 0.989)
Colorectal cancer	0.959 (0.938 to 0.979)	0.960 (0.940 to 0.980)	0.969 (0.953 to 0.984)	0.969 (0.954 to 0.984)	0.973 (0.959 to 0.986)	0.973 (0.959 to 0.986)
Incremental QALYs	3.6 (−10.7 to 17.9)		8.9 (−11.9 to 21.7)		4.4 (−12.6 to 21.5)
Incremental costs	89 053 (12 328 to 164 492)		83 127 (2922 to 162 538)		83 767 (3219 to 162 945)
Net Health Benefits	0.60 (−13.8 to 15.4)		1.93 (−15.5 to 19.4)		1.60 (−15.5 to 19.4)
Probability cost-effective	52.9		57.3		55.9

Figures represent the mean (95% interval) for 2000 simulations, except where indicated. QALYs costs and net health benefits are per 1000 participants.